Total net assets ($CAD):
$182.93 million

The top 15 holdings make up 68.09% of the Fund.
US Equity
International Equity
Cash and Equivalents
Canadian Equity
Other
United States
Japan
Germany
France
Canada
United Kingdom
Switzerland
Singapore
Brazil
Other
Healthcare
Consumer Services
Technology
Cash and Cash Equivalent
Financial Services
Real Estate
Other
Top holdings Sector allocation (%)
Bristol-Myers Squibb Co Drugs 5.89%
Alexion Pharmaceuticals Inc Drugs 5.83%
Takeda Pharmaceutical Co Ltd Drugs 5.57%
CVS Health Corp Retail 5.30%
Merit Medical Systems Inc Drugs 5.22%
Ionis Pharmaceuticals Inc Drugs 5.07%
SeaSpine Holdings Corp Diversified Healthcare 4.87%
Trupanion Inc Diversified Consumer Services 4.80%
Biogen Idec Inc Drugs 4.77%
Fresenius Medical Care AG & Co KGaA Healthcare Services 4.45%
Astellas Pharma Inc Drugs 4.08%
Intercept Pharmaceuticals Inc Drugs 3.69%
Sanofi SA Drugs 3.02%
Sangamo BioSciences Inc Diversified Healthcare 2.77%
Sugi Holdings Co Ltd Retail 2.76%
Asset allocation

US Equity 65.30%

International Equity 30.91%

Cash and Equivalents 2.19%

Canadian Equity 1.58%

Other 0.02%

Geographic allocation

United States 66.32%

Japan 12.41%

Germany 6.84%

France 3.02%

Canada 2.75%

United Kingdom 2.71%

Switzerland 2.26%

Singapore 1.34%

Brazil 1.33%

Other 1.02%

Sector allocation

Healthcare 79.71%

Consumer Services 12.86%

Technology 2.39%

Cash and Cash Equivalent 2.19%

Financial Services 1.95%

Real Estate 0.88%

Other 0.02%